Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in british girls

Environmental Health Perspectives

Volumn 120, Issue 10, 2012, Pages 1-26

  Maisonet, Mildred ^a,b   Terrell, Metrecia L ^a   McGeehin, Michael A ^b   Christensen, Krista Yorita ^a   Holmes, Adrianne ^b   Calafat, Antonia M ^b   Marcus, Michele ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

ALSPAC; Birth weight; Early childhood growth; Perfluorohexane sulfonate; Perfluorooctane sulfonate; Perfluorooctanoate; Polyfluoroalkyl compounds; Postnatal growth

Indexed keywords

PERFLEXANE; PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POLYFLUOROALKYL COMPOUND; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROHEXANESULFONIC ACID; SULFONIC ACID DERIVATIVE;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CHILD; CONTROLLED STUDY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INFANT; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MATERNAL SMOKING; MENARCHE; NEWBORN; POSTNATAL GROWTH; PREGNANT WOMAN; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; AGE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FETUS DEVELOPMENT; MULTIVARIATE ANALYSIS; POLLUTANT; PREGNANCY; REGRESSION ANALYSIS; UNITED KINGDOM;

ADOLESCENT; AGE FACTORS; ALKANESULFONIC ACIDS; BIRTH WEIGHT; BODY WEIGHT; CAPRYLATES; CHILD; COHORT STUDIES; ENGLAND; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MATERNAL EXPOSURE; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS; SULFONIC ACIDS;

EID: 84867184556     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003096     Document Type: Article

References (30)

1. Abbott BD, Wolf CJ, Schmid JE, Das KP, Zehr RD, Helfant L, et al. 2007. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci 98(2): 571-581.
2. Abbott BD, Wolf CJ, Das KP, Zehr RD, Schmid JE, Lindstrom AB, et al. 2009. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol 27(3-4): 258-265.
3. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115(11): 1670-1676.
4. ATSDR. 2009. Draft Toxicological Profile for Perfluoroalkyls.
5. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115(11): 1596-1602.
6. Casals-Casas C, Feige JN, Desvergne B. 2008. Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes (Lond) 32 Suppl 6: S53-61.
7. Christensen KY, Maisonet M, Rubin C, Holmes A, Calafat AM, Kato K, et al. 2010. Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort. Environ Int; doi: S0160-4120(10)00157-1 [pii] 10.1016/j.envint.2010.08.007 [Online Sep 13].
8. Cole TJ, Freeman JV, Preece MA. 1995. Body mass index reference curves for the UK, 1990. Arch Dis Child 73(1): 25-29.
9. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115(11): 1677-1682.
10. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2008. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 168(1): 66-72.
11. Golding J, Pembrey M, Jones R. 2001. ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 15(1): 74-87.
12. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, et. al. 2012. Prenatal Exposure to Perfluorooctanoate and Risk of Overweight at 20 Years of Age: A Prospective Cohort Study. Environ Health Perspect 120(5):668-673.
13. Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I. 2009. Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol; doi: 10.1038/jes.2009.5728 [Online 28 October 2009].
14. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE. 2009. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304(1-2): 97-105.
15. Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, et al. 2007. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 115(2): 226-230.
16. Kuklenyik Z, Needham LL, Calafat AM. 2005. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 77(18): 6085-6091.
17. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74(2): 382-392.
18. Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, et al. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90(2): 510-518.
19. Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL. 2005. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215(1-2): 126-148.
20. Maisonet M, Christensen KY, Rubin C, Holmes A, Flanders WD, Heron J, et al. 2010. Role of prenatal characteristics and early growth on pubertal attainment of British girls. Pediatrics 126(3): e591-600.
21. Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA. 2009. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27(3-4): 231-238.
22. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. 2000. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 320(7240): 967-971.
23. Richardson DB, Rzehak P, Klenk J, Weiland SK. 2007. Analyses of case-control data for additional outcomes. Epidemiology 18(4): 441-445.
24. Rolland-Cachera MF, Deheeger M, Guilloud-Bataille M, Avons P, Patois E, Sempe M. 1987. Tracking the development of adiposity from one month of age to adulthood. Ann Hum Biol 14(3): 219-229.
25. Rubin C, Maisonet M, Kieszak S, Monteilh C, Holmes A, Flanders D, et al. 2009. Timing of maturation and predictors of menarche in girls enrolled in a contemporary British cohort. Paediatr Perinat Epidemiol 23(5): 492-504.
26. Stein CR, Savitz DA, Dougan M. 2009. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170(7): 837-846.
27. Verbeke G, Molenberghs G. 1997. Springer Series in Statistics: Linear Mixed Models for Longitudinal Data. New York, New York, USA. Springer Publications.
28. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, et al. 2009. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117(4): 660-667.
29. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, et al. 2007. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96(1): 133-144.
30. Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, et al. 2007. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95(2): 462-473.